Canaan (CAN) Earnings Analysis
Canaan (CAN) next reports earnings on 2026-08-13, consensus EPS -0.1 USD. Last quarter (2026-05-19) it missed with EPS -0.13 USD vs -0.07 USD est (-85.7%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -0.78.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CAN next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.1 USD |
| Revenue estimate | 0.01B |
CAN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-19 | -0.13 USD | -0.07 USD | -85.7% | Miss |
| 2025-11-18 | -0.05 USD | -0.06 USD | +16.7% | Beat |
| 2025-08-14 | -0.03 USD | -0.13 USD | +76.9% | Beat |
| 2025-05-20 | -1.79 USD | -0.15 USD | -1093.3% | Miss |
| 2024-11-20 | -0.27 USD | -0.05 USD | -440% | Miss |
| 2024-08-15 | -0.15 USD | -0.3 USD | +50% | Beat |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
CAN valuation and analyst view
| Trailing P/E | -0.78 |
|---|---|
| Trailing EPS | -0.30751 USD |
| Price / book | 0.49 |
| Dividend yield | 0.00% |
| Market cap | 0.13B |
| Analyst consensus | Buy (6 buy / 0 hold / 0 sell) |
| Avg price target | 1.3 USD |
Related research pages
Frequently asked questions
When is Canaan (CAN)'s next earnings date?
Canaan is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.1 USD and revenue estimate of 0.01B.
Did CAN beat earnings last quarter?
In its 2026-05-19 report, CAN posted EPS of -0.13 USD versus a -0.07 USD estimate — a miss of 85.7%.
What is CAN's earnings track record?
Over the last 6 reported quarters with consensus data, CAN beat estimates 3 times (50%).
What is CAN's current P/E ratio and EPS?
CAN trades at a trailing P/E of -0.78 on trailing EPS of -0.30751249290123434 USD.
What do analysts rate CAN?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 1.3 USD.